Halofantrine: a new substance for treatment of multidrug-resistant malaria.
Nothdurft
H D
HD
Abteilung für Infektions- und Tropenmedizin, Ludwig-Maximilians-Universität, München.
Clemens
R
R
Bock
H L
HL
Löscher
T
T
D000208:Acute Disease; D000328:Adult; D000818:Animals; D000962:Antimalarials / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002675:Child, Preschool; D004341:Drug Evaluation; D006801:Humans; D015994:Incidence; D007223:Infant; D008288:Malaria / Q000453:epidemiology / Q000517:prevention & control; D016778:Malaria, Falciparum / Q000188:drug therapy*; D016780:Malaria, Vivax / Q000188:drug therapy; D010616:Phenanthrenes / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D010963:Plasmodium falciparum / Q000187:drug effects / Q000254:growth & development; D011446:Prospective Studies; D014195:Travel
D000962:Antimalarials; D010616:Phenanthrenes; C023768:halofantrine